Torrent Pharma received final approval for the Abbreviated New Drug Application from the US FDA for the Olanzapine orally disintegrated tablets in multiple strengths of 5mg, 10 mg, 15 mg, and 20 mg.
41032
Torrent Pharma received final approval for the Olanzapine orally disintegrated tablets
115672
FDA accepts Amgen's submission and files Biologics License Application for denosumab
33573
FDA approves denosumab for treatment of postmenopausal osteoporosis
90632
Scientists discover potential drug delivery system
56218
Ranbaxy launches cevimeline hydrochloride capsules in US market
1365
New drug strategy master plan being crafted --
19743
Boston Scientific assigned patent for drug delivery
154417
Lloydspharmacy launches co-branded generics
54889
Generics account for 80 per cent of US prescriptions
120096
Psychotropic medications associated with adverse drug reactions in Danish children:
131807
Drug delivery markets:
79082
Pharmaceutical industry faces collapse
92671
FDA approves Onglyza for Type 2 diabetes
61307
Advantest's terahertz spectroscopic/imaging system TAS7500 adopted by Astellas Pharma Inc.
66069
Targacept publicly offering 2.2 million shares
123993
FDA approves new drug for multiple sclerosis
51720
How prozac works